The SERNA Conceptual Standard for Cognitive Enhancement and Neuroethics: Definitions, Relationships, and Theoretical Integration (SCS-CEN)

Cognitive enhancement—the use of pharmacological, technological, or behavioral interventions to improve cognitive functions beyond the normal baseline—is an rapidly advancing field that presents profound ethical and neurobiological challenges. Despite its growing prominence, the field is characterized by significant terminological fragmentation regarding the distinction between "enhancement," "therapy," and "restoration." Researchers frequently conflate the temporary modulation of attention with the permanent augmentation of intelligence, leading to inconsistent findings and poorly defined ethical boundaries. This document presents the SERNA Conceptual Standard for Cognitive Enhancement and Neuroethics (SCS51), a unified theoretical framework designed to standardize definitions and model the causal pathways of cognitive augmentation. SCS51 establishes 12 canonical terms (SCS51-T01 through T12) that strictly differentiate between nootropic effects, brain-computer interfaces, and the ethical principles of autonomy, equity, and authenticity. The standard introduces the Augmentation-Integrity Trade-off (AIT) model, which incorporates 10 testable hypotheses (SCS51-H01 through H10) mapping the bi-directional relationships between enhancement efficacy and neurobiological homeostasis. By resolving 8 documented field inconsistencies—such as the "Enhancement vs. Therapy" dichotomy—SCS51 provides a rigorous foundation for cumulative science and policy-making in neuroethics.